Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Calvez

Showing results (161-170 of 329) with videos related to

Pageof 33
Sort By:
Antiviral Therapy|February 6, 2004
Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individualsClaudine Duvivier, Astriti Myrto, Anne-Geneviève Marcelin, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapyMarc Wirden, Constance Delaugerre, Anne Genevieve Marcelin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 6, 2004
Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipientsAnne-Geneviève Marcelin, Anne-Marie Roque-Afonso, Monika Hurtova, et al.
Journal of Virology|February 28, 2002
Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapyJohn Wilkinson, Alethea Cope, Jas Gill, et al.
Plos One|June 2, 2018
Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variantsMarine Perrier, Nathalie Désiré, Alexandre Storto, et al.
AIDS (London, England)|December 20, 2007
HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimenAnne-Geneviève Marcelin, Bernard Jarrousse, Anne Derache, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patientsMarc Wirden, Bénédicte Roquebert, Anne Derache, et al.
Antiviral Therapy|July 21, 2004
Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmissionConstance Delaugerre, Laurence Morand-Joubert, Marie-Laure Chaix, et al.
Journal of Medical Virology|May 20, 2005
Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patientsMarc Wirden, Anne Genevieve Marcelin, Anne Simon, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemiaMarc Wirden, Cathia Soulie, Marc-Antoine Valantin, et al.
Pageof 33

Showing results (161-170 of 329) with videos related to

Sort By:
Pageof 33
Antiviral Therapy|February 6, 2004
Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individualsClaudine Duvivier, Astriti Myrto, Anne-Geneviève Marcelin, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapyMarc Wirden, Constance Delaugerre, Anne Genevieve Marcelin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 6, 2004
Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipientsAnne-Geneviève Marcelin, Anne-Marie Roque-Afonso, Monika Hurtova, et al.
Journal of Virology|February 28, 2002
Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapyJohn Wilkinson, Alethea Cope, Jas Gill, et al.
Plos One|June 2, 2018
Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variantsMarine Perrier, Nathalie Désiré, Alexandre Storto, et al.
AIDS (London, England)|December 20, 2007
HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimenAnne-Geneviève Marcelin, Bernard Jarrousse, Anne Derache, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patientsMarc Wirden, Bénédicte Roquebert, Anne Derache, et al.
Antiviral Therapy|July 21, 2004
Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmissionConstance Delaugerre, Laurence Morand-Joubert, Marie-Laure Chaix, et al.
Journal of Medical Virology|May 20, 2005
Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patientsMarc Wirden, Anne Genevieve Marcelin, Anne Simon, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemiaMarc Wirden, Cathia Soulie, Marc-Antoine Valantin, et al.
Pageof 33